Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 18, Issue 4, Pages 399-409
Publisher
Informa UK Limited
Online
2017-01-28
DOI
10.1080/14656566.2017.1288717
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics
- (2017) Christopher E. Barbieri et al. EUROPEAN UROLOGY
- Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction
- (2016) Parag Goyal et al. AMERICAN JOURNAL OF MEDICINE
- Current and emerging therapies of HER2-positive metastatic breast cancer
- (2016) Abraham Hernández-Blanquisett et al. BREAST
- Heart Failure With Preserved Ejection Fraction
- (2016) James C. Fang CIRCULATION
- Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction
- (2016) Sanjiv J. Shah et al. CIRCULATION
- Relationship of Left Ventricular Diastolic Function to Obesity and Overweight in a Japanese Population With Preserved Left Ventricular Ejection Fraction
- (2016) Seitetsu L. Lee et al. CIRCULATION JOURNAL
- Inhaled Sodium Nitrite Improves Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection FractionNovelty and Significance
- (2016) Barry A. Borlaug et al. CIRCULATION RESEARCH
- Developing New Treatments for Heart Failure
- (2016) Mihai Gheorghiade et al. Circulation-Heart Failure
- Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure
- (2016) Ted Feldman et al. Circulation-Heart Failure
- Predicting Heart Failure With Preserved and Reduced Ejection FractionCLINICAL PERSPECTIVE
- (2016) Jennifer E. Ho et al. Circulation-Heart Failure
- One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE
- (2016) David M. Kaye et al. Circulation-Heart Failure
- Targeted cancer therapy: interactions with other medicines
- (2016) D. Conde-Estévez Clinical & Translational Oncology
- Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction
- (2016) Marta López-Sánchez et al. Clinical Respiratory Journal
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial
- (2016) David Fitchett et al. EUROPEAN HEART JOURNAL
- Reframing the association and significance of co-morbidities in heart failure
- (2016) Filippos Triposkiadis et al. EUROPEAN JOURNAL OF HEART FAILURE
- Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation
- (2016) Jozine M. ter Maaten et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction
- (2016) Dalane W. Kitzman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Glioblastoma multiforme targeted therapy: The Chlorotoxin story
- (2016) Or Cohen-Inbar et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Precision oncology: origins, optimism, and potential
- (2016) Vinay Prasad et al. LANCET ONCOLOGY
- Targeted Therapy and Immunotherapy for Lung Cancer
- (2016) Evan C. Naylor et al. Surgical Oncology Clinics of North America
- Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
- (2016) Rohan Samson et al. Journal of the American Heart Association
- One Week of Daily Dosing With Beetroot Juice Improves Submaximal Endurance and Blood Pressure in Older Patients With Heart Failure and Preserved Ejection Fraction
- (2016) Joel Eggebeen et al. JACC-Heart Failure
- Skeletal Muscle Mitochondrial Content, Oxidative Capacity, and Mfn2 Expression Are Reduced in Older Patients With Heart Failure and Preserved Ejection Fraction and Are Related to Exercise Intolerance
- (2016) Anthony J.A. Molina et al. JACC-Heart Failure
- Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
- (2016) Constantijn Franssen et al. JACC-Heart Failure
- Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease
- (2015) Simon Barquera et al. ARCHIVES OF MEDICAL RESEARCH
- Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?
- (2015) Sumeet S. Mitter et al. Current Atherosclerosis Reports
- Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial
- (2015) Elke S. Hoendermis et al. EUROPEAN HEART JOURNAL
- Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
- (2015) Scott D. Solomon et al. EUROPEAN HEART JOURNAL
- Heart failure with preserved ejection fraction: uncertainties and dilemmas
- (2015) Roberto Ferrari et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction
- (2015) Erin D. Unger et al. EUROPEAN JOURNAL OF HEART FAILURE
- Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review
- (2015) Carolyn L. Lekavich et al. HEART FAILURE REVIEWS
- Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial
- (2015) Gerd Hasenfuss et al. JOURNAL OF CARDIAC FAILURE
- Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction
- (2015) Barry A. Borlaug et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
- (2015) Margaret M. Redfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction
- (2014) Dalane W. Kitzman et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition
- (2014) Daniela Fraccarollo et al. BASIC RESEARCH IN CARDIOLOGY
- Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)
- (2014) Diana Bonderman et al. CHEST
- The Heart Failure Paradox: An Epidemic of Scientific Success
- (2014) Mariell Jessup CIRCULATION
- New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes
- (2014) M. Senni et al. EUROPEAN HEART JOURNAL
- Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
- (2014) Jennifer K. Rogers et al. EUROPEAN JOURNAL OF HEART FAILURE
- Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)
- (2014) Burkert Pieske et al. EUROPEAN JOURNAL OF HEART FAILURE
- NOX2-Induced Myocardial Fibrosis and Diastolic Dysfunction
- (2014) Robert J. Bache et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current Therapeutic Approach in Heart Failure with Preserved Ejection Fraction
- (2014) Jose Nativi-Nicolau et al. Heart Failure Clinics
- Epidemiology of Heart Failure with Preserved Ejection Fraction
- (2014) Charlotte Andersson et al. Heart Failure Clinics
- Phenotypic Spectrum of Heart Failure with Preserved Ejection Fraction
- (2014) Sanjiv J. Shah et al. Heart Failure Clinics
- Developing Therapies for Heart Failure With Preserved Ejection Fraction
- (2014) Javed Butler et al. JACC-Heart Failure
- Randomized, Double-Blind, Placebo-Controlled Study of Sitaxsentan to Improve Impaired Exercise Tolerance in Patients With Heart Failure and a Preserved Ejection Fraction
- (2014) Michael R. Zile et al. JACC-Heart Failure
- Left Ventricular Hypertrophy Patterns and Incidence of Heart Failure With Preserved Versus Reduced Ejection Fraction
- (2013) Raghava S. Velagaleti et al. AMERICAN JOURNAL OF CARDIOLOGY
- Ultrastructural and cellular basis for the development of abnormal myocardial mechanics during the transition from hypertension to heart failure
- (2013) Sanjiv J. Shah et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Increased echocardiographic epicardial fat thickness and high-sensitivity CRP level indicate diastolic dysfunction in patients with newly diagnosed essential hypertension
- (2013) Osman Turak et al. BLOOD PRESSURE MONITORING
- Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
- (2013) Francesco S. Loffredo et al. CELL
- Myocardial Titin and Collagen in Cardiac Diastolic Dysfunction
- (2013) Nazha Hamdani et al. CIRCULATION
- Preferences of heart failure patients in daily clinical practice: quality of life or longevity?
- (2013) Imke H. Kraai et al. EUROPEAN JOURNAL OF HEART FAILURE
- Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target
- (2013) N. Glezeva et al. HEART FAILURE REVIEWS
- Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
- (2013) Frank Edelmann et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction
- (2013) Margaret M. Redfield et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Matchmaking for the Optimization of Clinical Trials of Heart Failure With Preserved Ejection Fraction
- (2013) Sanjiv J. Shah JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin-16 Promotes Cardiac Fibrosis and Myocardial Stiffening in Heart Failure with Preserved Ejection Fraction
- (2013) Shunsuke Tamaki et al. PLoS One
- Increased Systemic Th17 Cytokines Are Associated with Diastolic Dysfunction in Children and Adolescents with Diabetic Ketoacidosis
- (2013) William H. Hoffman et al. PLoS One
- The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
- (2013) Stephen J. Greene et al. Journal of the American Heart Association
- Vascular inflammation and aortic stiffness relate to early left ventricular diastolic dysfunction in prehypertension
- (2012) Turgay Celik et al. BLOOD PRESSURE
- Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction
- (2012) Benjamin A. Steinberg et al. CIRCULATION
- Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
- (2012) Loek van Heerebeek et al. CIRCULATION
- Predictors of New-Onset Heart Failure
- (2012) Jennifer E. Ho et al. Circulation-Heart Failure
- Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community
- (2012) Jennifer E. Ho et al. EUROPEAN HEART JOURNAL
- Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women
- (2012) S Masiha et al. JOURNAL OF HUMAN HYPERTENSION
- Increased Arterial Wave Reflection Magnitude
- (2012) Sanjiv J. Shah et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Arterial Wave Reflections and Incident Cardiovascular Events and Heart Failure
- (2012) Julio A. Chirinos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- The many faces of heart failure with preserved ejection fraction
- (2012) Amil M. Shah et al. Nature Reviews Cardiology
- Ventricular–Vascular Interaction in Heart Failure
- (2011) Barry A. Borlaug et al. CARDIOLOGY CLINICS
- Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
- (2011) Marco Guazzi et al. CIRCULATION
- Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction
- (2011) Inder S. Anand et al. Circulation-Heart Failure
- Results of the Randomized Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction Trial (RAAM-PEF)
- (2011) Anita Deswal et al. JOURNAL OF CARDIAC FAILURE
- The Relationship Among Central Obesity, Systemic Inflammation, and Left Ventricular Diastolic Dysfunction as Determined by Structural Equation Modeling
- (2011) Cho-Kai Wu et al. Obesity
- Bosentan Effects on Hemodynamics and Clinical Outcome in Heart Failure Patients with Pulmonary Hypertension Awaiting Cardiac Transplantation
- (2011) T. Hefke et al. THORACIC AND CARDIOVASCULAR SURGEON
- Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
- (2010) Barry A. Borlaug et al. Circulation-Heart Failure
- Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
- (2010) Dirk Westermann et al. Circulation-Heart Failure
- Guanylyl cyclase activator ataciguat improves vascular function and reduces platelet activation in heart failure
- (2010) Andreas Schäfer et al. PHARMACOLOGICAL RESEARCH
- Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction
- (2009) Douglas S. Lee et al. CIRCULATION
- Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction
- (2009) Dirk J. van Veldhuisen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Choices: a Study of Preferences for End-of-life Treatments in Patients With Advanced Heart Failure
- (2008) Jane MacIver et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Changing Preferences for Survival After Hospitalization With Advanced Heart Failure
- (2008) Lynne W. Stevenson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
- (2008) Barry M. Massie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ventricular–Vascular Interaction in Heart Failure
- (2008) Barry A. Borlaug et al. Heart Failure Clinics
- Heart Failure with Preserved Ejection Fraction: Hypertension, Diabetes, Obesity/Sleep Apnea, and Hypertrophic and Infiltrative Cardiomyopathy
- (2008) Akshay Desai et al. Heart Failure Clinics
- Inflammatory pathways in patients with heart failure and preserved ejection fraction
- (2007) Margit Niethammer et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now